| Literature DB >> 32381045 |
Cristoforo Simonetto1, Michael Mayinger2,3, Thamer Ahmed2, Kai Borm2, Pavel Kundrát4, Steffi Pigorsch2,5, Jan Christian Kaiser4, Stephanie E Combs4,2,5.
Abstract
BACKGROUND: Radiotherapy treatment of head and neck cancer affects local arteries and increases the risk of stroke. This study aimed at a closer characterization of this damage and its development in time with a longitudinal study set up.Entities:
Keywords: Atherosclerosis; Diabetes mellitus; Hypopharyngeal carcinoma; Intima media thickness; Plaque; Radiotherapy
Mesh:
Year: 2020 PMID: 32381045 PMCID: PMC7206771 DOI: 10.1186/s13014-020-01541-3
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Characteristics of patients and treatments
| Treatment age [years] | Median: 60, range: 44–78 |
|---|---|
| Radiotherapy intent | 18 definitive |
| 6 adjuvant | |
| 1 palliative | |
| 1 additive | |
| Prescribed dose | 3 times 54/55 Gy |
| 7 times 64 Gy | |
| 17 times 70 Gy | |
| Chemotherapy | 16 (13 Cisplatin, 1 Carboplatin, 1 Cis- and Carboplatin, 1 Carboplatin and Paclitaxel) |
| History of cardiovascular disease | 6 (3 coronary artery disease, 3 peripheral artery occlusive disease, 1 atrial fibrillation, 1 aortic stenosis, 1 stroke) |
| History of hypertension | 10 |
| History of diabetes | 5 |
Increase in plaque number, plaque volume and intima media thickness for all patients included and for different subgroups. Tests for heterogeneity were applied to examine whether increase during follow-up was identical for two alternative subgroups
| Plaque number | Plaque volume [mm3] | Intima media thickness (IMT) [mm] | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before RT | Increase during follow-up | Test for significance | Before RT | Increase during follow-up | Test for significance | Before RT | Increase during follow-up | Test for significance | ||
| All patients | 5.7 | 2.4 | 249 | 77 | p = 0.26 | 1.17 | 0.19 | |||
| Prescribed dose < 70 Gy | yes | 6.8 | 2.3 | 308 | −16 | 1.23 | 0.16 | |||
| no | 4.7 | 2.4 | p = 0.06 | 198 | 157 | p = 0.13 | 1.15 | 0.20 | ||
| Test for heterogeneity | p > 0.5 | p > 0.5 | ||||||||
| Chemotherapy | yes | 2.7 | 1.5 | 108 | 81 | p = 0.13 | 1.18 | 0.20 | ||
| no | 8.3 | 3.1 | 370 | 73 | p > 0.5 | 1.14 | 0.16 | p = 0.25 | ||
| Test for heterogeneity | p > 0.5 | |||||||||
| Cardiovascular disease | yes | 13.7 | 5.0 | p = 0.25 | 709 | 194 | p > 0.5 | 1.27 | 0.14 | p = 0.5 |
| no | 3.3 | 1.6 | 111 | 47 | 1.14 | 0.20 | ||||
| Test for heterogeneity | p > 0.5 | p > 0.5 | ||||||||
| Hypertension | yes | 8.3 | 3.2 | p = 0.25 | 466 | −9 | p > 0.5 | 1.26 | 0.10 | p = 0.06 |
| no | 4.9 | 2.2 | 184 | 103 | p = 0.19 | 1.07 | 0.27 | p = 0.06 | ||
| Test for heterogeneity | p > 0.5 | |||||||||
| Diabetes mellitus | yes | 8.0 | 4.3 | p = 0.5 | 392 | −49 | p > 0.5 | 1.31 | 0.06 | p = 0.25 |
| no | 5.3 | 2.0 | 223 | 100 | p = 0.13 | 1.11 | 0.24 | |||
| Test for heterogeneity | p > 0.5 | |||||||||
| > 5 plaques before RT | yes | 12.6 | 3.9 | p = 0.06 | 633 | 116 | p > 0.5 | |||
| no | 1.4 | 1.4 | p = 0.06 | 9 | 52 | p = 0.13 | ||||
| Test for heterogeneity | p > 0.5 | |||||||||
| IMT > 1.2 mm before RT | yes | 1.28 | 0.18 | |||||||
| no | 0.99 | 0.21 | p = 0.13 | |||||||
| Test for heterogeneity | p > 0.5 | |||||||||
Fig. 1a Average (blue) and time-dependent (red) increase of the number of plaques (a) and intima media thickness (b). Bars represent 90% confidence intervals